Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluad versus Agrippal in previously unvaccinated children aged 6 to under 36 months
2010-023791-63Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in influenza comparing Fluad with Agrippal (2 arms). Primary endpoint: Cell-mediated immunity response. Started Jan 2011; status: completed.
02
Drugs
Fluzone Trivalentinfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-023791-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023791-63.